Sadia Rahman
Stock Analyst at Wells Fargo
(1.51)
# 3,533
Out of 5,023 analysts
17
Total ratings
50%
Success rate
-0.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sadia Rahman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintained: Buy | $55 | $26.37 | +108.57% | 5 | Sep 10, 2026 | |
| VOR Vor Biopharma | Maintained: Buy | $30 | $25.10 | +19.52% | 5 | Aug 31, 2026 | |
| DNTH Dianthus Therapeutics | Maintained: Buy | $135 | $109.13 | +23.71% | 6 | Aug 5, 2026 | |
| MDGL Madrigal Pharmaceuticals | Initiated Coverage: Buy | $685 | $534.16 | +28.24% | 1 | Jul 27, 2026 |
Maze Therapeutics
Sep 10, 2026
Maintained: Buy
Price Target: $55
Current: $26.37
Upside: +108.57%
Vor Biopharma
Aug 31, 2026
Maintained: Buy
Price Target: $30
Current: $25.10
Upside: +19.52%
Dianthus Therapeutics
Aug 5, 2026
Maintained: Buy
Price Target: $135
Current: $109.13
Upside: +23.71%
Madrigal Pharmaceuticals
Jul 27, 2026
Initiated Coverage: Buy
Price Target: $685
Current: $534.16
Upside: +28.24%